224 related articles for article (PubMed ID: 31118799)
1. lncRNA CADM1-AS1 inhibits cell-cycle progression and invasion via PTEN/AKT/GSK-3β axis in hepatocellular carcinoma.
Wang F; Qi X; Li Z; Jin S; Xie Y; Zhong H
Cancer Manag Res; 2019; 11():3813-3828. PubMed ID: 31118799
[No Abstract] [Full Text] [Related]
2. Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells.
Wu DM; Zheng ZH; Zhang YB; Fan SH; Zhang ZF; Wang YJ; Zheng YL; Lu J
J Exp Clin Cancer Res; 2019 Jun; 38(1):237. PubMed ID: 31171015
[TBL] [Abstract][Full Text] [Related]
3. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA NNT-AS1 promotes hepatocellular carcinoma progression and metastasis through miR-363/CDK6 axis.
Lu YB; Jiang Q; Yang MY; Zhou JX; Zhang Q
Oncotarget; 2017 Oct; 8(51):88804-88814. PubMed ID: 29179477
[TBL] [Abstract][Full Text] [Related]
5. Long Noncoding RNA GATA3-AS1 Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma by Suppression of PTEN, CDKN1A, and TP53.
Luo X; Zhou N; Wang L; Zeng Q; Tang H
Can J Gastroenterol Hepatol; 2019; 2019():1389653. PubMed ID: 31871924
[TBL] [Abstract][Full Text] [Related]
6. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
7. CADM1 regulates the G1/S transition and represses tumorigenicity through the Rb-E2F pathway in hepatocellular carcinoma.
Zhang W; Xie HY; Ding SM; Xing CY; Chen A; Lai MC; Zhou L; Zheng SS
Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):289-96. PubMed ID: 27298105
[TBL] [Abstract][Full Text] [Related]
8. HBx-related long non-coding RNA DBH-AS1 promotes cell proliferation and survival by activating MAPK signaling in hepatocellular carcinoma.
Huang JL; Ren TY; Cao SW; Zheng SH; Hu XM; Hu YW; Lin L; Chen J; Zheng L; Wang Q
Oncotarget; 2015 Oct; 6(32):33791-804. PubMed ID: 26393879
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA glypican 3 (GPC3) antisense transcript 1 promotes hepatocellular carcinoma progression via epigenetically activating GPC3.
Zhu XT; Yuan JH; Zhu TT; Li YY; Cheng XY
FEBS J; 2016 Oct; 283(20):3739-3754. PubMed ID: 27573079
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA ADAMTS9-AS1 exacerbates cell proliferation, migration, and invasion via triggering of the PI3K/AKT/mTOR pathway in hepatocellular carcinoma cells.
Zhang Z; Li H; Hu Y; Wang F
Am J Transl Res; 2020; 12(9):5696-5707. PubMed ID: 33042449
[TBL] [Abstract][Full Text] [Related]
11. lncRNA A1BG-AS1 suppresses proliferation and invasion of hepatocellular carcinoma cells by targeting miR-216a-5p.
Bai J; Yao B; Wang L; Sun L; Chen T; Liu R; Yin G; Xu Q; Yang W
J Cell Biochem; 2019 Jun; 120(6):10310-10322. PubMed ID: 30556161
[TBL] [Abstract][Full Text] [Related]
12. ADORA2A-AS1 Restricts Hepatocellular Carcinoma Progression
Pu J; Zhang Y; Wang A; Qin Z; Zhuo C; Li W; Xu Z; Tang Q; Wang J; Wei H
Front Oncol; 2021; 11():754835. PubMed ID: 34733789
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
[TBL] [Abstract][Full Text] [Related]
14. RHPN1-AS1 Drives the Progression of Hepatocellular Carcinoma via Regulating miR-596/IGF2BP2 Axis.
Fen H; Hongmin Z; Wei W; Chao Y; Yang Y; Bei L; Zhihua S
Curr Pharm Des; 2020; 25(43):4630-4640. PubMed ID: 31692433
[TBL] [Abstract][Full Text] [Related]
15. LncRNA TMEM220-AS1 suppresses hepatocellular carcinoma cell proliferation and invasion by regulating the TMEM220/β-catenin axis.
Liu Y; Liu R; Zhao J; Zeng Z; Shi Z; Lu Q; Guo J; Li L; Yao Y; Liu X; Xu Q
J Cancer; 2021; 12(22):6805-6813. PubMed ID: 34659569
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of LncRNA NR027113 inhibits cell proliferation and metastasis via PTEN/PI3K/AKT signaling pathway in hepatocellular carcinoma.
Chen Z; Zhou ZY; He CC; Zhang JL; Wang J; Xiao ZY
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7222-7232. PubMed ID: 30468465
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma.
Wang YD; Sun XJ; Yin JJ; Yin M; Wang W; Nie ZQ; Xu J
Biomed Pharmacother; 2018 Oct; 106():134-141. PubMed ID: 29957463
[TBL] [Abstract][Full Text] [Related]
18. [Role of lncRNA Fez family zinc finger protein 1 antisense RNA1 in hepatocellular carcinoma].
Yao J; Wang XP; Zhang ZZ; Yang J; Yang Z; Qian HX
Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):667-674. PubMed ID: 31550856
[No Abstract] [Full Text] [Related]
19. LncRNA-CCDC144NL-AS1 Promotes the Development of Hepatocellular Carcinoma by Inducing WDR5 Expression via Sponging miR-940.
Zhang Y; Zhang H; Wu S
J Hepatocell Carcinoma; 2021; 8():333-348. PubMed ID: 33977095
[TBL] [Abstract][Full Text] [Related]
20. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B
Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]